Search Within

Vicky Makker

Formats
  1. Meeting Abstract (142)
  2. Journal Article (110)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (267)
  2. GDMT, Medicine (267)
  3. Gynecologic Medicine Service (267)
  4. Gynecology Disease Management Team (267)
  5. Solid Tumor Oncology Division (267)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (11)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (36)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (74)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (37)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (12)
  6. Wiley Blackwell (9)

More Publishers

Results (267)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational analysis of GOG 248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Myers, A. P.; Filiaci, V. L.; Zhang, Y.; Pearl, M.; Behbakht, K.; Makker, V.; Hanjani, P.; Zweizig, S.; Burke, J. J. 2nd; Downey, G.; more...
    Gynecologic Oncology (2016)

    Fulltext@MSK | Save
  • Survival of patients with uterine carcinosarcoma undergoing sentinel lymph node mapping
    Journal Article

    Schiavone, M. B.; Zivanovic, O.; Zhou, Q.; Leitao, M. M. Jr; Levine, D. A.; Soslow, R. A.; Alektiar, K. M.; Makker, V.; Iasonos, A.; Abu-Rustum, N. R.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Do stages I–II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma?
    Meeting Abstract

    Yang, T. J.; Desai, N.; Kollmeier, M.; Makker, V.; Leitao, M. M.; Abu-Rustum, N. R.; Alektiar, K.
    Gynecologic Oncology (2015)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer
    Meeting Abstract

    Voss, M.; Gordon, M. S.; Mita, M.; Rini, B.; Makker, V.; Macarulla, T.; Smith, D.; Kwak, E. L.; Cervantes, A.; Puzanov, I.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Pilot study evaluating presence of crown-like structures in high grade endometrial carcinoma
    Meeting Abstract

    Shu, C. A.; Iyengar, N. M.; Giri, D. D.; Chiang, S.; Williams, S.; Konner, J. A.; Aghajanian, C.; Hudis, C. A.; Dannenberg, A.; Makker, V.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
    Meeting Abstract

    Myers, A. P.; Filiaci, V. L.; Zhang, Y. P.; Pearl, M.; Behbakht, K.; Makker, V.; Hanjani, P.; Zweizig, S.; Burke, J. J.; Downey, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save